 Ridogrel setting percutaneous transluminal coronary angioplasty safety combination heparin ridogrel therapy antiplatelet efficacy setting percutaneous transluminal coronary angioplasty PTCA patients aspirin days PTCA therapy ridogrel intravenous bolus PTCA dose mg discharge Heparin IU bolus dose PTCA intravenous infusion rate IU/hour hours problems arterial entry site patients blood transfusion patients patient underwent emergency bypass surgery specific problems hemostasis Ridogrel thromboxane serum ml vs ml hours ridogrel concomitant increase serum alpha ml vs ml hours ridogrel acute reocclusions ridogrel-treated patients acute reocclusions patients standard aspirin heparin regimen period clinical follow-up patients ridogrel standard treatment